Long-term experience and wide competence pool enable agile co-creation of next generation medical devices together with customers.
Recent Posts
The healthcare technology industry is evolving with various global trends. In recent years, one trend has been clear: software and data-driven solutions are revolutionizing the future of patient...
FlowOx 2.0, developed in co-creation between Norwegian company Otivio AS and Innokas Medical, is a clinically promising, patented and cost-efficient home treatment solution for Peripheral Arterial...
It has been noted that the occurrence of use errors, also called as human error, increases the number and severity of incidents related to the use of medical devices. Use errors typically occur when...
Across industries, the pace to introduce new products is increasing. This puts pressure on companies to shorten the design and development cycles. Medical devices are no exception in this respect.
With their next-generation innovation, Synoste aims to renew surgical treatment related to bone deformities. Innokas Medical is involved in this mission by being one of Synoste's co-creation partners...
Healthcare technology is one of the largest high-tech export segments of Finnish industry, and it continues to grow strongly year after year. In addition to growth, the industry is evolving with...
WellO2, innovation developed by the Finnish company WellO2 Oy (formerly known as Hapella Oy), is a breathing exercise device that strengthens and cleanses the lungs. The mission of the company is to...
The collaborative consortium has received a significant funding from Business Finland. This two-year Stroke-DATA -project, which is one part of Business Finland’s Smart Life program, is carried out...
